PDF下载 ( 123 KB)
Regulation of sex hormone on sex difference in fatty liver
-
-
[1]Malaguarnera M, Di Rosa M, Nicoletti F, et al.Molecular mecha-nisms involved in NAFLD progression[J].J Mol Med, 2009, 87 (7) :679-695. [2]Shimizu I, Kohno N, Tamaki K, et al.Female hepatology:favorable role of estrogen in chronic liver disease with hepatitis B virus infection[J].World J Gastroenterol, 2007, 13 (32) :4295-4305. [3]Lee CM, Lu SN, Changchien CS, et al.Age, gender, and local ge-ographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection[J].Cancer, 1999, 86 (7) :1143-1150. [4]Chiu CM, Yeh SH, Chen PJ, et al.Hepatitis B virus X protein en-hances androgen receptor-responsive gene expression depending on androgen level[J].Proc Natl Acad Sci US A, 2007, 104 (8) :2571-2578. [5]Wang SH, Yeh SH, Lin WH, et al.Identification of androgen re-sponse elements in the enhancer I of hepatitis B virus:a mechanism for sex disparity in chronic hepatitis B[J].Hepatology, 2009, 50 (5) :1392-1402. [6]Liu WH, Yeh SH, Lu CC, et al.MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells[J].Gastroenterology, 2009, 136 (2) :683-693. [7]Codes L, Asselah T, Cazals-Hatem D, et al.Liver fibrosis in women with chronic hepatitis C:evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replace-ment therapy[J].Gut, 2007, 56 (3) :390-395. [8]McKenzie J, Fisher BM, Jaap AJ, et al.Effects of HRTon liver en-zyme levels in women with type2diabetes:a randomized placebo-controlled trial[J].Clin Endocrinol (Oxf) , 2006, 65 (1) :40-44. [9]Saibara T, Onishi S, Ogawa Y, et al.Bezafibrate for tamoxifen-in-duced non-alcoholic steatohepatitis[J].Lancet, 1999, 353 (9166) :1802. [10]Ogawa Y, Murata Y, Nishioka A, et al.Tamoxifen-induced fatty liver in patients with breast cancer[J].Lancet, 1998, 351 (9104) :725. [11]Nemoto Y, Toda K, Ono M, et al.Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice[J].J Clin Invest, 2000, 105 (12) :1819-1825. [12]Pitteloud N, Mootha VK, Dwyer AA, et al.Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men[J].Diabetes Care, 2005, 28 (7) :1636-1642. [13]Kintzel PE, Chase SL, Schultz LM, et al.Increased risk of meta-bolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer[J].Pharmacotherapy, 2008, 28 (12) :1511-1522. [14]Yanase T, Fan W, Kyoya K, et al.Androgens and metabolic syn-drome:lessons from androgen receptor knock out (ARKO) mice[J].J Steroid Biochem Mol Biol, 2008, 109 (25) :254-257. [15]Lin HY, Xu Q, Yeh S, et al.Insulin and leptin resistance with hy-perleptinemia in mice lacking androgen receptor[J].Diabetes, 2005, 54 (6) :1717-1725. [16]Lin HY, Yu IC, Wang RS, et al.Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor[J].Hepatology, 2008, 47 (6) :1924-1935. [17]Chen CL, Yang HI, Yang WS, et al.Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection:a follow-up study in Taiwan[J].Gastroenterology, 2008, 135 (1) :111-121. [18]Moriya K, Yotsuyanagi H, Shintani Y, et al.Hepatitis C virus core protein induces hepatic steatosis in transgenic mice[J].J Gen Vir-ol, 1997, 78 (Pt7) :1527-1531. [19]Wu BK, Li CC, Chen HJ, et al.Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice[J].Biochem Biophys Res Commun, 2006, 340 (3) :916-928. [20]Kim KH, Shin HJ, Kim K, et al.Hepatitis B virus X protein in-duces hepatic steatosis via transcriptional activation of SREBP1and PPARgamma[J].Gastroenterology, 2007, 132 (5) :1955-1967. -
本文二维码
计量
- 文章访问数: 3354
- HTML全文浏览量: 5
- PDF下载量: 1005
- 被引次数: 0
下载:
